Friday, December 9, 2011

Study finds impotence risk higher in men taking several drugs

NEW YORK (Reuters Health) -

Men taking multiple medications for different health conditions may have a higher risk of erectile dysfunction -- a link that doesn't seem to be explained by the health problems themselves, a new study finds.

Overall, 16 percent of men on no more than two drugs reported moderate ED -- meaning they "sometimes" had trouble getting or maintaining an erection. That compared with 20 percent of men on three to five medications, a quarter of men on six to nine drugs and 31 percent of those on at least 10 drugs.

Not surprisingly, ED was more common in men who were older, heavier, smoked or had health problems like diabetes or high blood pressure. But even when the researchers accounted for that, being on multiple medications was still tied to an increased ED risk.

Senior researcher Dr. Steven J. Jacobsen said that it's possible the drugs themselves could contribute to or worsen ED -- via drug interactions, for instance. But there's no way to tell for sure from these findings.

What is clear, he stressed, is that men with erectile problems should not simply stop taking their prescriptions.


Read more details here:
Study finds impotence risk higher in men taking several drugs


Thursday, December 8, 2011

Some men can delay prostate cancer treatment: panel

CHICAGO (Reuters) -

Men with low-risk prostate cancer may wait to see if their disease progresses before treating it, an independent panel of experts convened by the U.S. National Institutes of Health (NIH) said on Wednesday.

Although this is almost 'common knowledge' these days, it's nice to see the NIH adding it's weight to the argument.


Read the full article here:
Some men can delay prostate cancer treatment


Wednesday, December 7, 2011

Prostate cancer hormonal therapy cuts deaths: report

NEW YORK (Reuters Health) -

For men with aggressive prostate cancer, hormone-targeted therapy cuts the overall risk of death, according to a new review of past studies.

It also does not increase the chance that men will die from cardiovascular disease -- which some research had suggested might be the case.

So-called androgen deprivation therapy, or ADT, has been the standard of treatment for men with more aggressive, high-risk prostate cancers. The drugs suppress the body's production of testosterone, which is known to speed cancer growth.

But they've also been linked to side effects including hot flashes, weight gain, diabetes and loss of sex drive -- and, more recently, to cardiovascular risks. One recent study linked hormone-targeted therapy to an increased risk of blood clots.

Read more here:

Prostate cancer hormonal therapy cuts deaths